Navigation Links
John McKearn, Ph.D., Promoted to Managing Director of RiverVest Venture Partners
Date:5/3/2011

ST. LOUIS, May 3, 2011 /PRNewswire/ -- RiverVest Venture Partners®, a venture capital firm investing in emerging medical technology and biopharmaceutical companies, today announced that John McKearn, Ph.D., has been promoted to Managing Director.  

Dr. McKearn joined RiverVest as Venture Partner in 2008, bringing extensive scientific and operational expertise in pharmaceutical research and development as former president and CEO of Kalypsys, Inc.; head of discovery research for Pharmacia and Searle; and senior scientist with E.I. DuPont de Nemours and Company.

"John has been a valuable addition to the RiverVest team and we are pleased to promote him," said Jay Schmelter, RiverVest Managing Director. "His deep knowledge of pharmaceutical research and development is instrumental in enhancing the drug development programs of our portfolio companies and securing important venture capital financing opportunities."

Most recently, Dr. McKearn helped originate and structure a $38.5 million Series B financing for Otonomy, Inc., a clinical stage biopharmaceutical company developing novel drug therapies for disorders of the inner and middle ear. The deal, which closed in August 2010, was co-led by Novo Ventures and RiverVest Venture Partners, and joined by TPG Biotech, Domain Associates and Avalon.

"This is an exciting time for RiverVest," said Dr. McKearn. "As a team, we are uniquely positioned in a marketplace that has been defined in recent years as harsh, frenetic and out of balance. We continue to leverage our deep operating experience to attract and shape promising biopharmaceutical opportunities and build value for our portfolio companies."  

Dr. McKearn holds a Ph.D. in immunology from the University of Chicago and a B.S. in biology from Northern Illinois University. He currently serves as a member of the board of directors for Otonomy, Inc., and has served on the boards of IDM Pharma, Inc. (acquired by Takeda),
'/>"/>

SOURCE RiverVest Venture Partners
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. ChromaDex Appoints Curtis Lockshin, Ph.D., to its Board of Directors
2. Heiner Dreismann, Ph.D., Former President of Roche Molecular Systems, Joins the HistoRx Board of Directors
3. WaferGen Names Gary P. Schroth, Ph.D., as New SVP, Genomics Research and Applications
4. Fibrocell Science, Inc. Names Biotechnology and Genetic Research Expert Stefan Gruenwald, M.D., Ph.D., to Scientific Advisory Board
5. American Humane Association Announces Joy Mench, Ph.D., Joins the Scientific Advisory Committee of the American Humane Certified® Farm Animal Program
6. Melissa Kemp, Ph.D., Wins the Council for Systems Biology in Boston (CSB2) Award Sponsored by Merrimack Pharmaceuticals, Inc.
7. ChemoCentryx President and CEO, Thomas J. Schall, Ph.D., Named Ernst & Young Entrepreneur Of The Year 2010 Award Finalist in Northern California
8. Fate Therapeutics Appoints Tom Novak, Ph.D., as Vice President of Research and Drug Discovery
9. Chimerix Names George Painter, Ph.D., Chairman of the Board and Chief Scientific Officer; Appoints Kenneth I. Moch President and Chief Executive Officer
10. 5th Annual Szent-Gyorgyi Prize for Progress in Cancer Research Awarded to Peter K. Vogt, Ph.D., The Scripps Research Institute
11. Orameds Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the Third International Conference on Advanced Technologies and Treatments for Diabetes in Basel, Switzerland
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... On Wednesday of last week RENU 28, the ... molecules, became available for purchase in Australia and New Zealand, ... RENU 28 works is, if you think about the definition ... of cellular renewal within your body. If you think about ... of cellular renewal. What RENU 28 does is it works ...
(Date:8/20/2014)... measuring vibrational motion of a single molecule with a ... a single molecule differs from the behaviour of larger ... the University of California, Irvine, where post-doctoral researcher Eero ... visiting fellow under professor Vartkess A. Apkarian, whose team ... by Professor Eric O. Potma. The results of the ...
(Date:8/20/2014)... 20, 2014  PAREXEL International Corporation (NASDAQ: ... at the Baird Healthcare Conference in New York.  ... Officer, will be making a presentation on PAREXEL and ... Sept. 3, 2014. A live webcast of ... of PAREXEL,s website at www.PAREXEL.com in the ...
(Date:8/20/2014)... the health of your heart, researchers have discovered. , ... standard TENS machine like those designed to relieve labour ... small raised flap at the front of the ear ... stimulation changed the influence of the nervous system on ... drive failing hearts too hard. , Professor Jim Deuchars, ...
Breaking Biology Technology:RENU 28 Skin Care Now Available in Australia and New Zealand 2Seeing a molecule breathe 2PAREXEL International To Present At Baird Healthcare Conference 2'Tickling' your ear could be good for your heart 2
... N.J., Oct. 4 In conjunction with,its third quarter 2007 ... 24), Covance Inc. (NYSE: CVD ) is pleased to ... will be broadcast,live over the Internet on Thursday, October 25 ... Quarter 2007 Earnings Webcast and Slide Presentation When: ...
... Inc.,(NYSE: SMA ), an independent provider of ... medical markets, announced today that the Audit,Committee of ... review of,apparent irregularities with respect to the Company,s ... unit. The review follows a,report by management earlier ...
... today announced that Solomon Steiner, Chairman and CEO of Biodel,will ... San,Francisco, CA on October 11th at 11:00 AM PT. ... webcast of the,presentation in the investor relations section of Biodel,s ... be available for,14 days. About Biodel Inc. Biodel ...
Cached Biology Technology:Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement 2Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement 3Biodel Inc. to Present at BIO InvestorForum 2007 Conference on October 11, 2007 2
(Date:8/21/2014)... smog-producing toxins in past decade, GTA still violates ... that while the Greater Toronto Area (GTA) has ... to smog, the city continues to violate the ... can cause or aggravate health problems such as ... a set of complex photochemical reactions involving volatile ...
(Date:8/21/2014)... 2014 Nxt-ID, Inc. (OTCQB: NXTD), a biometric ... announced today that its shares of common stock and ... in its proposed underwritten public offering of common stock ... Nasdaq Capital Market, subject to closing of its proposed ... and will trade under the symbol "NXTD" and "NXTDW," ...
(Date:8/21/2014)... are the ultimate source of all organic matter that ... algae, too, to suck up climate-warming carbon dioxide from ... the ocean. Now, by using a combination of satellite ... viruses infecting those algae are driving the life-and-death dynamics ... essentially the same, and this has important implications for ...
Breaking Biology News(10 mins):Despite a significant reduction in smog-producing toxins, the Greater Toronto Area still violates Canada's standards for ozone air pollution 2Nxt-ID Approved for NASDAQ Capital Market Listing 2Nxt-ID Approved for NASDAQ Capital Market Listing 3Viruses take down massive algal blooms, with big implications for climate 2
... Boston, MA - Tiny particles only billionths of a meter ... human haircould offer big hope in a small package to the ... everything from jewelry to coins and cell phones, say scientists at ... issue of Nature Nanotechnology, the team will report a ...
... the largest study of its kind, researchers from a consortium ... linked to late-onset Alzheimer,s disease. Each of these genes adds ... the disease, and together they offer a portal into the ... to determine who is at risk of developing the disease, ...
... Medicine researchers are part of a consortium that has identified ... a person developing Alzheimer,s disease later in life. The ... The consortium also contributed to the identification of a ... United States and Europe. "Mount Sinai has unique resources ...
Cached Biology News:Nanoparticles offer hope for common skin allergy 2Nanoparticles offer hope for common skin allergy 3Alzheimer’s disease consortium identifies four new genes for Alzheimer’s disease risk 2Alzheimer’s disease consortium identifies four new genes for Alzheimer’s disease risk 34 new genes identified for Alzheimer's disease risk 2
UBC13 Antibody...
HLA II DG+DR+DP Monoclonal Antibody, Purified, Unconjugated, Clone: IQU9 This antibody is specific for the monomorphic determinant of the HLA Class II beta chains of the human MHC (28 kDa)....
Phenytoin-BSA Isolated IgY DFc Drug...
Tropomyosin 4 [Tm4]...
Biology Products: